当前位置:首页 - 行情中心 - 方盛制药(603998) - 财务分析 - 资产负债表

方盛制药

(603998)

  

流通市值:47.40亿  总市值:47.96亿
流通股本:4.34亿   总股本:4.40亿

资产负债表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
流动资产:
货币资金276,995,730.26208,977,378.63190,147,631.01192,873,026.87
应收票据及应收账款259,505,624.95209,642,956.21242,193,290.8251,392,931.91
应收账款259,505,624.95209,642,956.21242,193,290.8251,392,931.91
应收款项融资8,505,845.2821,446,104.754,378,285.347,319,064.88
预付款项87,697,168.38104,803,769.71126,435,445.12100,829,943.52
其他应收款合计10,731,797.413,499,500.5176,243,750.57179,365,410.49
存货364,761,515.23328,284,076.31372,029,805.67367,013,039.73
其他流动资产12,213,243.8913,689,349.787,933,899.8519,094,847.57
流动资产平衡项目0000
流动资产合计1,040,737,121.39920,669,331.891,144,717,915.361,138,248,104.97
非流动资产:
长期应收款149,229,212.63149,229,212.63--
长期股权投资260,307,469.19257,523,643.72259,691,325.9261,619,092.01
其他非流动金融资产1111
投资性房地产10,285,526.9610,436,771.218,311,646.272,884,564.24
固定资产814,668,109.13812,688,967.48808,624,240.35817,649,374.62
在建工程262,352,653.38217,529,979.54196,163,669.64142,129,006.81
使用权资产20,367,711.1821,089,130.1523,252,444.5523,963,358.96
无形资产263,712,067.04267,677,587.69257,922,951.26262,887,537.21
开发支出--702,587.1685,555.55
商誉274,405,463.36274,405,463.36273,926,850.63273,926,850.63
长期待摊费用18,510,090.7418,132,612.7719,072,624.7618,455,307.82
递延所得税资产16,335,958.8415,604,532.5110,666,986.2910,491,686.66
其他非流动资产122,916,712.92115,998,435.41101,388,968.988,281,491.9
非流动资产平衡项目0000
非流动资产合计2,213,090,976.372,160,316,337.471,959,724,296.651,902,973,827.41
资产平衡项目0000
资产总计3,253,828,097.763,080,985,669.363,104,442,212.013,041,221,932.38
流动负债:
短期借款418,480,000309,194,403.62315,450,138.89226,015,416.67
应付票据及应付账款260,436,651.05245,816,473.99245,136,936.92260,593,819.44
其中:应付票据135,742,050.09132,192,387.96128,275,319.43136,319,802.25
应付账款124,694,600.96113,624,086.03116,861,617.49124,274,017.19
预收款项2,737,5322,805,391.8--
合同负债19,439,495.5536,176,324.9623,219,006.8323,077,399.52
应付职工薪酬18,566,708.6932,164,329.9119,410,464.2221,450,869.77
应交税费32,903,63420,852,376.1629,578,328.2523,653,114.26
其他应付款合计453,911,900.72400,327,020.45439,524,891.5462,354,910.26
一年内到期的非流动负债14,111,235.8196,502,110.3272,616,269.2668,544,855.55
其他流动负债2,476,796.844,250,768.312,461,678.483,186,433.44
流动负债平衡项目0000
流动负债合计1,223,063,954.651,248,089,199.521,147,397,714.351,088,876,818.91
非流动负债:
长期借款282,277,862.93152,696,762.52285,736,930.56296,343,998.07
租赁负债21,811,836.9521,308,249.1623,100,721.6123,658,453.11
长期应付款2,344,235.662,415,663.5621,850,267.340,777,986.14
预计负债-380,000--
递延收益32,021,452.0732,860,389.533,020,832.3733,642,120.94
递延所得税负债33,948,074.4534,509,420.4430,532,248.7131,120,824.62
非流动负债平衡项目0000
非流动负债合计372,403,462.06244,170,485.18394,241,000.55425,543,382.88
负债平衡项目0000
负债合计1,595,467,416.711,492,259,684.71,541,638,714.91,514,420,201.79
所有者权益(或股东权益):
实收资本(或股本)439,586,860439,733,620439,733,620440,451,120
资本公积187,707,065.56185,822,420.74180,025,911.12179,716,922.18
减:库存股15,316,99517,000,55017,000,55032,961,150
其他综合收益-74,869.54-74,869.54-74,869.54-74,869.54
盈余公积133,730,977.13133,730,977.13112,006,471.81112,006,471.81
未分配利润786,132,270.5715,882,077.85708,130,723.9696,848,269.67
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计1,531,765,308.651,458,093,676.181,422,821,307.291,395,986,764.12
少数股东权益126,595,372.4130,632,308.48139,982,189.82130,814,966.47
股东权益平衡项目0.01000
股东权益合计1,658,360,681.061,588,725,984.661,562,803,497.111,526,801,730.59
负债和股东权益合计3,253,828,097.763,080,985,669.363,104,442,212.013,041,221,932.38
公告日期2024-04-202024-04-202023-10-262023-08-31
审计意见(境内)标准无保留意见
TOP↑